login

Varying Nicotine Patch Dose and Type of Smoking Cessation Counseling

JAMAPublished 1 November 1995
Douglas E. Jorenby
Citations228
SJR quartileQ1
SJR score5.35
SNIP10.71

TL;DR

There does not appear to be any general, sustained benefit of initiating transdermal nicotine therapy with a 44-mg patch dose or of providing intense adjuvant smoking cessation treatment.

Abstract

There does not appear to be any general, sustained benefit of initiating transdermal nicotine therapy with a 44-mg patch dose or of providing intense adjuvant smoking cessation treatment. The two doses and all adjuvant treatments produced equivalent effects at the 26-week follow-up, and the higher patch dose produced more adverse effects. Higher-dose (44-mg) nicotine replacement does not appear to be indicated for general clinical populations, although it may provide short-term benefit to some smokers attempting to quit with minimal adjuvant treatment.

Keywords

MedicineHealth Professions